Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5949 USD | -1.51% | -0.85% | +12.25% |
Apr. 16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
Financials (USD)
Sales 2022 | 10.93M | Sales 2023 | 9.77M | Capitalization | 9.36M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -2M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M | Net cash position 2023 | 5.78M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | 30 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
1 day | -1.51% | ||
1 week | -0.85% | ||
Current month | -4.03% | ||
1 month | -5.57% | ||
3 months | +36.76% | ||
6 months | +50.23% | ||
Current year | +12.25% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | Dec. 10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.5949 | -1.51% | 76 118 |
24-05-03 | 0.604 | -0.92% | 118,207 |
24-05-02 | 0.6096 | -0.78% | 44,472 |
24-05-01 | 0.6144 | -0.89% | 53,654 |
24-04-30 | 0.6199 | +3.32% | 71,559 |
Delayed Quote Nasdaq, May 06, 2024 at 03:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.25% | 10.67M | |
+22.79% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.39% | 25.55B | |
-21.08% | 19.27B | |
-1.41% | 12.15B | |
+30.52% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- BGLC Stock